Licensed Practical Nurse in North Haven, CT Accepting Medicare

3 Licensed Practical Nurse nurses found. Showing 1 - 3

Ms. Nichole Barnes, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 352 State St, North Haven, CT 06473 Phone: 203-781-4600    Fax: 203-781-4624

Mary Bieluczyk, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 352 State St, North Haven, CT 06473 Phone: 203-781-4600    Fax: 203-781-4624

Mr. John Demayo, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 352 State St, North Haven, CT 06473 Phone: 203-781-4600    Fax: 203-781-4624

News Archive

Resveratrol inhibits proliferation of hormone resistant breast cancer cells

Cheers! A new research report appearing in the October 2011 issue of The FASEB Journal shows that resveratrol, the "healthy" ingredient in red wine, stops breast cancer cells from growing by blocking the growth effects of estrogen.

Research provides new insights into eating disorders in Native Americans

The research, published in the International Journal of Eating Disorders, provides new insights into the extent to which Native American populations experience eating disorders, revealing that women are more likely to report behavioral symptoms then men, while challenging views that NA men and ethnically white men will experience different psychological symptoms.

WHO's recommendation for malaria vaccine offers a glimmer of hope for Sub-Saharan Africa

The World Health Organization's recommendation of broad deployment of the first malaria vaccine among children in Sub-Saharan Africa has been widely celebrated, but scientists warn it could face hurdles in its acquisition and distribution by endemic countries.

FDA approves INFUSE® bone graft which improves fracture healing

Medtronic, Inc. has announced that the U.S. Food and Drug Administration (FDA) approved the use of INFUSE® Bone Graft in the treatment of acute, open fractures of the tibial shaft, a long bone in the lower leg. The approval broadens the indications for INFUSE Bone Graft, a product that has been used since 2002 in spinal surgery with metallic cages to treat tens of thousands of patients.

Myriad Genetics highlights three new studies at SABCS 2014

Myriad Genetics, Inc. today announced results from a new study that demonstrated the ability of the myRisk Hereditary Cancer test to detect 105 percent more mutations in cancer causing genes than conventional BRCA testing alone. The Company also presented two key studies in triple negative breast cancer (TNBC) that show the myChoice HRD test accurately predicted response to platinum-based therapy in patients with early-stage TNBC and that the BRACAnalysis molecular diagnostic test significantly predicted response to platinum-based drugs in patients with metastatic TNBC.

Read more Medical News

› Verified 7 days ago